Molly C. Erdman

Molly C. Erdman

Auto-generated profile, based on publicly available information

Molly C. Erdman

Center for Computational and Genomic Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Science Advances
Verified
Journal Article
Open access
DHDaniel Hwang
Daniel Hwang
MEMolly C. Erdman
Molly C. Erdman
SASantosh Adhikari
Santosh Adhikari
RPRam Pantula
Ram Pantula
KEKaya Epstein
Kaya Epstein
NSNikolaos G. Sgourakis
Nikolaos G. Sgourakis
Epitopic peptides presented by class-I human leukocyte antigen (HLA-I) proteins provide the basis of immune surveillance by T cells. Conversely, reduced surface HLA-I expression is a hallmark of immune evasion by latent viral infections and cancer, which confounds the identification of peptide antigens and neoantigens. Here, we outline a system (HLA-Shuttle) for in vitro manipulation of cells with engineered components of the HLA-I processing machinery to confer a continuum of chaperoning activity throughout their trafficking pathway. HLA-Shuttle restores antigen presentation in immunologically cold neuroblastoma cells, enabling identification of multiple tumor-associated antigens with therapeutic potential. Cellular trafficking assays and single-particle tracking reveal a global stabilization of HLA-I molecules, extension of their cell-surface lifetime and microdomain formation. HLA-Shuttle can be used across a range of aberrant cellular states where low antigen expression remains a bottleneck for the identification of endogenous peptide antigens.

21 March 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MEMolly C. Erdman
Molly C. Erdman
KEKaya Epstein
Kaya Epstein
DHDaniel Hwang
Daniel Hwang
RKRadia M.M. Khan
Radia M.M. Khan
SSShirley M. Sun
Shirley M. Sun
NSNikolaos G. Sgourakis
Nikolaos G. Sgourakis
Human leukocyte antigen (HLA) proteins are extremely polymorphic, with different allotypes exhibiting a wide range of dependencies on the chaperone tapasin for peptide loading, expression, and stability at the cell surface. Given its central role in antigen processing, tapasin is frequently downregulated across viral infections and cancers, impairing antigen presentation and hindering the identification of therapeutically relevant peptide antigens. We hypothesized that elucidating the mutational tolerance of tapasin surfaces, which mediate interactions with polymorphic HLA residues, can provide a means for fine-tuning its chaperoning function and reveal mechanistic epitopes that underlie its function. Using two complementary deep mutational scanning screens, we systematically mapped the tapasin/HLA-A∗02:01 interaction landscape, highlighting key regions involved in HLA-I assembly and repertoire optimization. We engineered two high-fidelity tapasin variants, tapasin-YTY and tapasin-I2, and show that these variants can increase cell surface HLA expression on a wild-type (WT) tapasin-deficient background by up to 50% and improve peptide-loading function across multiple HLA-A∗ allotypes. Our findings establish scanning mutagenesis as a general approach for fine-tuning chaperone interactions with HLA molecules to enhance antigen presentation in immunologically impaired settings.

12 June 2026 in Science Advances
Verified
Journal Article
Open access
HPHoang Anh T. Phan
Hoang Anh T. Phan
SESoomin Eom
Soomin Eom
DHDaniel Hwang
Daniel Hwang
MYMichael C. Young
Michael C. Young
SSShirley M. Sun
Shirley M. Sun
NSNikolaos G. Sgourakis
Nikolaos G. Sgourakis
MHC-I proteins present epitopic peptides to CD8 + T cells to elicit multifaceted adaptive immune responses. The affinity and avidity of interactions between peptide-MHC molecules and their cognate T cell receptors (TCRs) are fundamental parameters that contribute to the induction of activated or anergic T cell states. Here, we present a multivalent, loadable platform, VLP-Open HLA, featuring a virus-like particle (VLP) which can display up to 60 peptide/HLA [human leukocyte antigen (HLA)] molecules. VLP-Open HLA can be used to stain antigen-specific CD8 + T cells, providing a screening tool for orphan TCRs. When combined with costimulation, VLP-Open HLA acts as an artificial antigen-presenting platform to induce antigen-specific T cell activation and expansion, providing a facile alternative to autologous antigen-presenting cells. Our platform can be adapted to encompass multiple HLA allotypes and costimulatory molecules as mosaic nanoparticles, enabling a range of applications in experimental immunology.